NCT07699133

Brief Summary

This prospective observational study aims to evaluate the neurological safety of controlled hypotension (Mean Arterial Pressure 50-65 mmHg) during elective rhinoplasty. The investigators will assess whether this standard intraoperative hypotensive strategy causes cellular stress by measuring serum Glial Fibrillary Acidic Protein (GFAP) levels and early postoperative cognitive changes using the Montreal Cognitive Assessment (MoCA) test.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started Jul 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Jul 2026Mar 2027

First Submitted

Initial submission to the registry

July 7, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

July 10, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 13, 2026

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2027

Last Updated

July 14, 2026

Status Verified

July 1, 2026

Enrollment Period

8 months

First QC Date

July 7, 2026

Last Update Submit

July 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Serum Glial Fibrillary Acidic Protein (GFAP) Level

    GFAP is a biomarker of astrocyte stress and blood-brain barrier permeability. Measured via ELISA (pg/mL).

    Baseline (T0: Post-induction) and 24 hours postoperatively (T1).

Secondary Outcomes (2)

  • Change in Montreal Cognitive Assessment (MoCA) Score

    Baseline (Preoperative ward visit) and 24 hours postoperatively.

  • Duration of Target Hypotension

    Intraoperative period (from surgical incision to end of surgery, approximately 1-3 hours).

Study Arms (1)

Controlled Hypotension Cohort

Patients undergoing elective rhinoplasty receiving standard intraoperative controlled hypotension (Target MAP: 50-65 mmHg) maintained with sevoflurane and remifentanil.

Procedure: Controlled Hypotension (Standard of Care)

Interventions

Maintenance of Mean Arterial Pressure (MAP) between 50 and 65 mmHg during the surgical procedure to optimize the surgical field.

Controlled Hypotension Cohort

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of adult patients, aged 18 to 50 years, who are scheduled to undergo elective primary rhinoplasty or septorhinoplasty under general anesthesia at the Department of Otorhinolaryngology and Plastic Surgery, Kahramanmaras Sutcu Imam University Hospital. Patients will be selected from those with an American Society of Anesthesiologists (ASA) physical status of I or II, ensuring a healthy cohort without severe systemic diseases.

You may qualify if:

  • Scheduled for elective rhinoplasty or septorhinoplasty under general anesthesia.
  • ASA physical status I or II.
  • Literate and willing to provide written informed consent.

You may not qualify if:

  • History of neurological (e.g., cerebrovascular event, epilepsy) or psychiatric diseases.
  • Total septal reconstruction requiring costal (rib) cartilage grafts.
  • Expected surgical duration exceeding 3 hours.
  • Preoperative severe cognitive impairment.
  • Pregnancy or lactation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Hypotension, ControlledStandard of Care

Intervention Hierarchy (Ancestors)

Anesthesia and AnalgesiaQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cengizhan Yavuz, MD, Assistant Professor, Department of Anesthesiology and Reanimation

Study Record Dates

First Submitted

July 7, 2026

First Posted

July 13, 2026

Study Start

July 10, 2026

Primary Completion (Estimated)

February 28, 2027

Study Completion (Estimated)

March 30, 2027

Last Updated

July 14, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will share

De-identified individual participant data (IPD) that underlie the results reported in the final publication will be shared upon reasonable request. Data will only be shared for academic, non-commercial purposes to ensure compliance with personal data protection regulations.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will become available beginning 6 months and ending 36 months following the publication of the primary research article.
Access Criteria
Data will be shared with researchers who provide a methodologically sound research proposal. Requests should be directed to the corresponding author via email. Requestors will be required to sign a data access agreement.